Cash Flow OSE Immunotherapeutics SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
34.00
-29.00
-23.00
-21.00
-24.00
-4.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
0.00
-3.00
1.00
-2.00
8.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
47.00
-19.00
-18.00
-9.00
-19.00
8.00
Cash Flow from Investing Activities
-46.00
0.00
0.00
0.00
0.00
2.00
Cash Flow from Financing Activities
-2.00
13.00
10.00
14.00
23.00
4.00
Net Cash Inflow / Outflow
-1.00
-6.00
-7.00
4.00
3.00
16.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of OSE Immunotherapeutics SA
Figures in Million
consolidated Cash Flow Results
Change(EUR)
Change(%)
Profit Before Tax
34.53
-39.9448731049134
73.00
186.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.98
49.6121462501198
-48.00
-96.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
47.971
20.4698060611228
27.00
134.35%
Cash Flow from Investing Activities
-46.909
-95.0438000872508
49.00
50.64%
Cash Flow from Financing Activities
-2.989
83.1660985122664
-85.00
-103.59%
Net Cash Inflow / Outflow
-1.927
6.04793926708812
-7.00
-131.86%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-2.54416521905021
2.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 342.72% vs -8.28% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
47.97
-19.76
342.72%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
